J&J Finalizes $26 Billion Opioid Settlement
MONDAY, Feb. 28, 2022 (HealthDay News) — Settlements totaling $26 billion have been finalized between drugmaker Johnson & Johnson plus three major pharmaceutical distributors and state and local governments, over the companies’ role in America’s opioid crisis. The settlement plan — involving Johnson & Johnson, AmerisourceBergen, Cardinal Health and McKessonContinue Reading